Quick Claim Pro manages the full endocrinology revenue cycle — from insurance verification before the first referral visit through CGM and insulin pump prior authorization, claim submission, denial management, AR follow-up, and quarterly reporting — for endocrinology practices across all 50 states.
First-Pass Claim Acceptance Rate
Days in AR — Endocrinology Benchmark
Denial Rate Post-Outsourcing
Free Endocrinology Billing Audit Delivered
The same patient often carries multiple active benefit layers — medical, pharmacy, and DME — and CGM, insulin pump, and specialty injectable claims each follow distinct, quarterly-changing payer rules that vary across all 50 states.
A payer-specific scrubbing layer validates CPT-ICD-10 pairing (E11.65 vs. E11.9), modifier -25 and -59 application, RPM 16-day threshold compliance, and MAC-jurisdiction LCD requirements before every 837P transmits — catching the proprietary bundling rules that UnitedHealthcare, Aetna, BCBS, and Cigna apply beyond standard NCCI edits.
Every denial is worked within 72 hours and categorized across 6 root-cause categories — medical necessity (CO-50), ICD-10 specificity (CO-11), prior auth mismatch (CO-197), modifier audit flags (CO-4/CO-22), and LCD non-compliance (N115) — each resolved with the specific clinical evidence the payer’s own coverage policy requires.
Structured follow-up protocols track diabetes E/M visits, CGM claims, insulin pump DME billing, and CCM encounters separately by aging bucket, with priority queues for insulin pump and specialty injectable claims and supervisor-level escalation for underpayment review against the 2026 MPFS conversion factor.
Every ERA is posted within 4 hours and flagged when payment deviates from the contracted rate by more than $2 — catching the underpayment-as-contractual-adjustment problem that silently erodes CGM interpretation and RPM revenue across a 200-patient panel.
Clear communication of out-of-pocket responsibility for CGM supplies, insulin pump initiation, specialty injectables, and DEXA scans before the patient is surprised by a balance — coordinated with benefit verification so cost-sharing is explained before the service, not after the statement.
PECOS enrollment under taxonomy code 207RE0101X, CAQH ProView management with quarterly re-attestation, coordinated multi-payer credentialing across Medicare, Medicaid, and commercial plans, and NP/CDCES credentialing under incident-to rules where applicable.
Level 1 appeals cite the payer’s own coverage policy verbatim — Aetna CPB 0070 for CGM, UHC CDG.00260 for insulin pumps — addressing each denial criterion with matching clinical evidence, with peer-to-peer scheduling before the appeal window closes and Level 2/QIC escalation tracked to 180 days.
A 24-month audit targets underpaid CGM interpretation claims (CPT 95251), missed chronic care management billing, under-captured RPM management time, and insulin pump HCPCS underpayments — identified through systematic CPT-utilization analysis against the patient panel, not individual claim review.
Monthly reporting tracks CGM program performance, specialty injectable PA approval rate by payer, quarterly payer scorecards, and year-over-year revenue trend by CPT category — surfacing performance problems 30 to 60 days before they show up in collections.
Performance benchmarks delivered for endocrinology practices across the US.
“We were billing CPT 99454 for our CGM patients but had no system for confirming the 16-day threshold before submission. Aetna denied 31 claims in one quarter. Quick Claim Pro restructured our RPM billing workflow and recovered $14,200 from those denials. Our CGM billing capture rate went from 67 percent to 96 percent in 90 days.”
Houston Medical Center Corridor, Texas
“Our prior authorization failure rate on semaglutide and tirzepatide was running at 34 percent because our team was submitting requests without the step therapy documentation Cigna requires. Quick Claim Pro built the authorization template with that documentation included. Approval rate went from 66 percent to 91 percent in the first month.”
Buckhead Medical District, Atlanta, Georgia
“We had 18 months of unbilled CPT 99490 encounters for our diabetic patients with multiple chronic conditions. Quick Claim Pro’s old AR audit identified $31,400 in recoverable chronic care management revenue and submitted corrected claims across UnitedHealthcare, BCBS Illinois, and Medicare. We collected $27,800 of that within 60 days.”
Chicago Medical District Endocrinology Group, Illinois
First-pass acceptance rate (83% CMS national average)
Denial rate post-outsourcing (15–22% specialty average)
Days in AR (60+ days common per Health Quest 2026)
Average revenue increase
Endocrinology-specific billing expertise combined with the structural accountability independent practices need from an outsourced revenue cycle partner.
Billers with direct knowledge of the CPT 95250/95251 and 99453–99458 code families, the 16-day data threshold, and the medical-versus-pharmacy benefit pathway — not general billers applying a diabetes code list.
UnitedHealthcare, Aetna, BCBS, and Cigna each maintain proprietary bundling rules for CGM and RPM codes that standard NCCI edit tables miss — caught before transmission, not after denial.
GLP-1 receptor agonist prior authorizations built with the metformin and sulfonylurea trial-failure documentation Cigna, UHC, Aetna, and BCBS require before approving semaglutide or tirzepatide.
A Business Associate Agreement is executed before accessing any patient or practice data — standard on every engagement, no exceptions.
No long-term contracts, no early termination fees, no setup fees — Quick Claim Pro earns continued engagement through performance, not contract length.
Free front-end revenue cycle audit identifies CGM billing gaps, PA failure patterns, and AR aging issues before the engagement begins.
Real-world benchmark data for payer behavior and endocrinology-specific denial pattern analysis across commercial and government payers.
Endocrinology practices that outsource to Quick Claim Pro report an average 20% increase in collected revenue, driven by CGM and CCM capture recovery.
Clean claim rate on CGM and RPM codes, denial rate by payer and CPT category, AR aging breakdown, and prior authorization failure patterns reviewed. Results delivered within 48 hours.
The Business Associate Agreement is executed before accessing any patient records, claim data or payer correspondence.
Integration with your existing EHR or PM system, with endocrinology-specific claim scrubbing rules — CGM benefit pathway, ICD-10 specificity, modifier logic — configured inside it.
Active enrollment status verified for every billing provider with Medicare, Medicaid and commercial payers — closing credentialing gaps before the first claim goes out.
Clean endocrinology claims transmit within days of full EHR integration, with CGM and RPM documentation checks active from the first submission batch.
CPT 95251 is the correct code for CGM data interpretation and report — the professional component of continuous glucose monitoring analysis. CPT 95250 covers sensor placement, hook-up, and patient training. These codes are not interchangeable: 95250 is billed when the device is initiated, 95251 when the endocrinologist interprets the data. Medicare covers one interpretation per 30-day period under LCD L38657.
CGM claims are denied when the submitted ICD-10 code does not meet the payer’s medical necessity criteria. UHC requires E11.65 (on insulin), not the unspecified E11.9. Aetna requires documented insulin use for at least 6 months. Claims submitted with E11.9 or without insulin documentation are denied under CO-50 regardless of clinical reality. The fix is ICD-10 specificity and documentation-first submission.
QlaimPro identifies your denial rate by CPT cluster, AR aging exposure, prior authorization approval gaps, and estimated recoverable revenue — before you make any outsourcing decision.
